Eczema drug may lift mood: new study targets mental health
NCT ID NCT07467564
First seen Mar 27, 2026 · Last updated May 25, 2026 · Updated 8 times
Summary
This study follows 184 adults with moderate-to-severe atopic dermatitis (eczema) who also have anxiety or depression. All participants are already starting dupilumab as part of their regular care. Researchers will track changes in anxiety, depression, and quality of life over 6 months to see if treating the skin condition improves mental health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NMC Specialty Hospital LTD
RECRUITINGAbu Dhabi, United Arab Emirates
-
Saudi Medical Services (Medical Fakeeh)
RECRUITINGJeddah, 21331, Saudi Arabia
Conditions
Explore the condition pages connected to this study.